Key Stories from the past week: Updates and Elections

Key Stories from the past week: Updates and Elections

Macro
Saxo Be Invested
Saxo

The week was pot marked with a number corporate stories grabbing client attention. We saw sharp downwards price moves in Airbus, Micron, GSK, Alfen, Nike with the discounts attracting new positions taking for the most part. Novo Nordisk reached a new landmark with the share price breaking DKK 1,00 after Chinese approval of its obesity drug Wegowy. We also note that Nvidia’s three day sell off at the start of the week means we are starting to see slow down in new positions being opened.

Micron falls short of market expectations 
Micron shares dropped -9% following its latest earnings release despite the memory chipmaker reporting better-than-expected revenue figures in the previous quarter and indicated higher than estimated revenue figures for the current quarter. AI demand is driving 50% QoQ data centre revenue growth and so the market reaction underscores the high expectations for every company that is part of the AI ecosystem.
Why Micron is weighing on Nvidia and other chip stocks

Alfen update rocks investors
Shares in Alfen NV almost halved after adjusting 2024 guidance and the assessment of mid-term objectives. The specialist energy equipment and solutions provider now anticipate a slower market for 2024 due to postponed large deals, supply chain issues and slower EV battery sales. 2024 revenue outlook is lowered to €485-520m from €590-660m, free cash flow to be negative. A number of large Energy Storage Systems deals originally anticipated to sign in Q2 are being postponed and will likely only contribute to 2025 revenue, causing ESS 2024 revenue to decline by approximately 20% compared to 2023.
Alfen rout

Stubborn inflation prints sets up for a key ECB policy meeting next week
French stocks lag their regional peers ahead of Sunday’s parliamentary election. French bonds also dropped, underperforming their German counterparts. Investors retain a cautious stance on French financial assets due to the high event risks and the slim chances of meaningful fiscal consolidation, regardless of the election result. Individual movers among French companies included L’Oreal SA which fell after the beauty-products maker said it expects slower growth in the overall beauty market this year. Planemaker Airbus dropped -9% after lowering its 2024 delivery forecast. Air France-KLM fell -11% over the past week as political risk invited analyst downgrades.
Market awaits the first round of French election voting

Next week brings the result of the first round of the French legislative election. Economic data highlights include; Germany CPI June, US ISM Manufacturing June (Monday), Eurozone CPI June, Fed Chair Jerome Powel, US JOLTS May (Tuesday), US ISM Non-Manufacturing, FOMC Minutes (Wednesday), UK General Election (Thursday), US Non-Farm payrolls June (Friday). It’s a quiet for earnings with Constellation Brands due to report (Wednesday), from there we will begin to look forward to the Q2 earnings season kick off the following week.


Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992